Stella Pharma Corporation (TYO:4888)
Japan flag Japan · Delayed Price · Currency is JPY
309.00
-7.00 (-2.22%)
Oct 29, 2025, 3:30 PM JST

Stella Pharma Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212019 - 2020
Period Ending
Oct '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2019 - 2020
10,51713,0359,08711,48517,281-
Upgrade
Market Cap Growth
-42.99%43.45%-20.88%-33.54%--
Upgrade
Enterprise Value
8,39410,3967,50110,14614,767-
Upgrade
Last Close Price
309.00383.00291.00387.00603.00-
Upgrade
PS Ratio
10.6013.5633.7850.15172.82-
Upgrade
PB Ratio
3.454.073.824.175.61-
Upgrade
P/TBV Ratio
3.504.133.914.275.74-
Upgrade
P/FCF Ratio
-95.85----
Upgrade
P/OCF Ratio
-93.11----
Upgrade
EV/Sales Ratio
8.4610.8227.8844.31147.68-
Upgrade
EV/FCF Ratio
-76.44----
Upgrade
Debt / Equity Ratio
0.240.240.390.400.416.14
Upgrade
Debt / FCF Ratio
-5.63----
Upgrade
Asset Turnover
0.200.210.070.050.030.09
Upgrade
Inventory Turnover
0.100.100.050.030.030.07
Upgrade
Quick Ratio
15.8410.055.346.5810.694.09
Upgrade
Current Ratio
21.6613.447.989.0113.565.67
Upgrade
Return on Equity (ROE)
-4.69%-5.01%-29.76%-26.68%-46.36%-143.26%
Upgrade
Return on Assets (ROA)
-0.94%-1.22%-11.66%-11.14%-13.69%-18.08%
Upgrade
Return on Capital (ROIC)
-1.27%-1.54%-13.28%-12.32%-15.50%-21.79%
Upgrade
Earnings Yield
-1.28%-1.07%-8.40%-6.77%-4.44%-
Upgrade
FCF Yield
-1.04%-9.75%-7.43%-6.52%-
Upgrade
Buyback Yield / Dilution
-8.66%-7.76%-7.27%-2.83%-40.17%-28.43%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.